TriangleSOLAR (NCT06607549)
SOLAR trial for Central Nervous System Lymphoma (NCT06607549). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with central nervous system lymphoma that has relapsed, or that is untreated in patients who cannot have high dose methotrexate.
The idea: after stereotactic radiosurgery to the brain, give loncastuximab tesirine and rituximab by vein for six cycles.
This phase 1 study plans 12 patients and looks for a safe, tolerable dose of the combination after radiosurgery. At Huntsman Cancer Institute at the University of Utah, Narendranath Epperla leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.